Trials / Completed
CompletedNCT07110740
Bioequivalence Study Between UI009 and UIC202005 in Healthy Subjects
A Randomized, Open-label, Single-dosing, 2x2 Crossover Study to Evaluate Bioequivalence After Dry-powder Inhalation of UIC202005 or UI009 in Healty Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Korea United Pharm. Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A Randomized, Open-label, Single-dosing, 2x2 Crossover Study to Evaluate Bioequivalence After Dry-powder Inhalation of UIC202005 or UI009 in Healty Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | UI009 | inhale UI009 twice a day on Day 1 and Day 8. |
| DRUG | UIC202005 | inhale UIC202005 twice a day on Day 1 and Day 8. |
Timeline
- Start date
- 2024-10-24
- Primary completion
- 2024-11-29
- Completion
- 2024-12-13
- First posted
- 2025-08-08
- Last updated
- 2025-08-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07110740. Inclusion in this directory is not an endorsement.